These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 11342669

  • 1. Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis.
    Wang HB, Shi FD, Li H, Chambers BJ, Link H, Ljunggren HG.
    J Immunol; 2001 May 15; 166(10):6430-6. PubMed ID: 11342669
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis.
    Im SH, Barchan D, Souroujon MC, Fuchs S.
    J Immunol; 2000 Oct 01; 165(7):3599-605. PubMed ID: 11034361
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
    Araga S, Galin FS, Kishimoto M, Adachi A, Blalock JB.
    J Immunol; 1996 Jul 01; 157(1):386-92. PubMed ID: 8683141
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cellular immune response to acetylcholine receptors in murine experimental autoimmune myasthenia gravis: inhibition with monoclonal anti-I-A antibodies.
    Christadoss P, Lindstrom J, Talal N.
    Cell Immunol; 1983 Oct 01; 81(1):1-8. PubMed ID: 6577968
    [Abstract] [Full Text] [Related]

  • 13. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.
    Araga S, LeBoeuf RD, Blalock JE.
    Proc Natl Acad Sci U S A; 1993 Sep 15; 90(18):8747-51. PubMed ID: 8378359
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis.
    Dedhia V, Goluszko E, Wu B, Deng C, Christadoss P.
    Clin Immunol Immunopathol; 1998 Jun 15; 87(3):266-75. PubMed ID: 9646836
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An immunodominant site of acetylcholine receptor in experimental myasthenia mapped with T lymphocyte clones and synthetic peptides.
    Pachner AR, Kantor FS, Mulac-Jericevic B, Atassi MZ.
    Immunol Lett; 1989 Feb 15; 20(3):199-204. PubMed ID: 2469649
    [Abstract] [Full Text] [Related]

  • 19. Immunotherapy of experimental autoimmune myasthenia gravis: selective effects of CTLA4Ig and synergistic combination with an IL2-diphtheria toxin fusion protein.
    McIntosh KR, Linsley PS, Bacha PA, Drachman DB.
    J Neuroimmunol; 1998 Jul 01; 87(1-2):136-46. PubMed ID: 9670855
    [Abstract] [Full Text] [Related]

  • 20. T cell responses in EAMG-susceptible and non-susceptible mouse strains after immunization with overlapping peptides encompassing the extracellular part of Torpedo californica acetylcholine receptor alpha chain. Implication to role in myasthenia gravis of autoimmune T-cell responses against receptor degradation products.
    Oshima M, Yokoi T, Deitiker P, Atassi MZ.
    Autoimmunity; 1998 Jul 01; 27(2):79-90. PubMed ID: 9583739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.